Lv5
1178 积分 2025-05-23 加入
Mutational landscape and tyrosine kinase inhibitor sensitivity in EGFR L833 and H835 mutated non–small cell lung cancer
1天前
待确认
[Epithelial growth factor receptor (EGFR) exon double-sequencing analysis in NSClC]
1天前
求助中
Osimertinib
1天前
已完结
Primary and secondary resistance mechanisms in first, second and third generation tyrosine kinase inhibitors in EGFR mutant non-small cell lung cancer patients
1天前
求助中
Clinical and Molecular Characterization of a Rare EGFR cis Compound L833V/H835L Mutation in Non-Small Cell Lung Cancer
1天前
已完结
Good response to gefitinib in a lung adenocarcinoma harboring a heterozygous complex mutation of L833V and H835L in epidermal growth factor receptor gene
1天前
已完结
A sequential method of epidermal growth factor receptor mutation detection reduces false negatives: a new case with doublet mutations of L833V and H835L in China
1天前
已完结
Ferroptosis of immune cells in the tumor microenvironment
24天前
已完结
CH7233163 Overcomes Osimertinib-Resistant EGFR-Del19/T790M/C797S Mutation
29天前
已完结
Overcoming EGFR(T790M) and EGFR(C797S) resistance with mutant-selective allosteric inhibitors
29天前
已完结
皖公网安备34019202002308
